Omni Bridgeway backs class action against J&J in New Zealand

Omni Bridgeway is funding a class action brought by JGA Saddler Lawyers (NZ) against Johnson & Johnson on behalf of all individuals in New Zealand who have purchased Codral, Sudafed or Benadryl branded oral cold and flu medicines containing Phenylephrine (“PE”) as the active ingredient during the period of 2005 to 2025. PE has recently been found by the FDA to be no more effective than a placebo in relieving cold and flu symptoms when used orally. Read more.

Omni Bridgeway is funding a parallel class action in Australia.